Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method ...

Coupled with the invalidation of 10x Genomics’ 10,155,981 patent ... a fundamentally differentiated solution that makes single cell sequencing more scalable without the need for expensive ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

X Genomics Inc . (NASDAQ:TXG) reported its Q4 2024 earnings, revealing a larger-than-expected loss per share and a decline in revenue compared to the previous year. The company posted an EPS of -$0.40 ...

Many studies have used single-cell RNA sequencing (scRNA-seq) to infer gene regulatory networks (GRNs), which are crucial for ...

Founded in 2012, 10x Genomics (NASDAQ:TXG) develops single-cell and spatial genomics solutions, enabling researchers to ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other stocks in Cathie Wood’s portfolio. Cathie Wood is one of Wall Street’s most ...

This collaboration will use 10x Genomics' Chromium GEM-X technology for single-cell analysis ... "Initiatives like the Billion Cells Project showcase advances enabled by our innovative sequencing ...

This collaboration will use 10x Genomics' Chromium GEM-X technology for single-cell ... like the Billion Cells Project showcase advances enabled by our innovative sequencing architecture combined ...